Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

BACKGROUND: Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between metaplastic breast cancer and triple-negative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Surg Oncol
Autors principals: Morgan, Evan, Suresh, Anupama, Ganju, Akaansha, Stover, Daniel G., Wesolowski, Robert, Sardesai, Sagar, Noonan, Anne, Reinbolt, Raquel, VanDeusen, Jeffrey, Williams, Nicole, Cherian, Mathew A., Li, Zaibo, Young, Gregory, Palettas, Marilly, Stephens, Julie, Liu, Joseph, Luff, Amanda, Ramaswamy, Bhuvaneswari, Lustberg, Maryam
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961248/
https://ncbi.nlm.nih.gov/pubmed/31937323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-019-1780-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars